What is Colgate Palmolive Co's earnings per share (EPS)?

Colgate Palmolive Co (CL) reported diluted earnings per share of $2.63 for fiscal year 2025. This represents a -25.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Colgate Palmolive Co Financials

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Colgate Palmolive Co (CL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 46/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Colgate Palmolive Co has an operating margin of 16.2%, meaning the company retains $16 of operating profit per $100 of revenue. This results in a moderate score of 58/100, indicating healthy but not exceptional operating efficiency. This is down from 21.2% the prior year.

Growth

Colgate Palmolive Co's revenue grew a modest 1.4% year-over-year to $20.4B. This slow but positive growth earns a score of 36/100.

Leverage

Colgate Palmolive Co has elevated debt relative to equity (D/E of 127.24), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Colgate Palmolive Co's current ratio of 0.83 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 11/100, which could limit financial flexibility.

Cash Flow

Colgate Palmolive Co converts 17.8% of revenue into free cash flow ($3.6B). This strong cash generation earns a score of 70/100.

Returns

100

Colgate Palmolive Co earns a strong 3948.1% return on equity (ROE), meaning it generates $3948 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100. This is up from 1362.7% the prior year.

Altman Z-Score Safe

6.68

Colgate Palmolive Co scores 6.68, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

5/9

Colgate Palmolive Co passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.97x

For every $1 of reported earnings, Colgate Palmolive Co generates $1.97 in operating cash flow ($4.2B OCF vs $2.1B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

12.4x

Colgate Palmolive Co earns $12.4 in operating income for every $1 of interest expense ($3.3B vs $267.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$20.4B

YoY+1.4%

5Y CAGR+4.4%

10Y CAGR+2.4%

Colgate Palmolive Co generated $20.4B in revenue in fiscal year 2025. This represents an increase of 1.4% from the prior year.

EBITDA

$3.9B

YoY-19.2%

5Y CAGR-2.3%

10Y CAGR+2.0%

Colgate Palmolive Co's EBITDA was $3.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 19.2% from the prior year.

Net Income

$2.1B

YoY-26.2%

5Y CAGR-4.6%

10Y CAGR+4.4%

Colgate Palmolive Co reported $2.1B in net income in fiscal year 2025. This represents a decrease of 26.2% from the prior year.

EPS (Diluted)

$2.63

YoY-25.1%

5Y CAGR-3.5%

10Y CAGR+5.6%

Colgate Palmolive Co earned $2.63 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 25.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$3.6B

YoY+2.5%

5Y CAGR+1.9%

10Y CAGR+4.9%

Colgate Palmolive Co generated $3.6B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 2.5% from the prior year.

Cash & Debt

$1.3B

YoY+17.5%

5Y CAGR+7.7%

10Y CAGR+2.9%

Colgate Palmolive Co held $1.3B in cash against $6.9B in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.08

YoY-16.1%

5Y CAGR+3.5%

Colgate Palmolive Co paid $2.08 per share in dividends in fiscal year 2025. This represents a decrease of 16.1% from the prior year.

Shares Outstanding

802M

YoY-1.2%

5Y CAGR-1.1%

10Y CAGR-1.1%

Colgate Palmolive Co had 802M shares outstanding in fiscal year 2025. This represents a decrease of 1.2% from the prior year.

Margins & Returns

Gross Margin

60.1%

YoY-0.4pp

5Y CAGR-0.7pp

10Y CAGR+1.5pp

Colgate Palmolive Co's gross margin was 60.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the prior year.

Operating Margin

16.2%

YoY-5.0pp

5Y CAGR-7.4pp

10Y CAGR-1.2pp

Colgate Palmolive Co's operating margin was 16.2% in fiscal year 2025, reflecting core business profitability. This is down 5.0 percentage points from the prior year.

Net Margin

10.5%

YoY-3.9pp

5Y CAGR-5.9pp

10Y CAGR+1.8pp

Colgate Palmolive Co's net profit margin was 10.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.9 percentage points from the prior year.

Return on Equity

3948.1%

YoY+2585.4pp

5Y CAGR+3585.4pp

Colgate Palmolive Co's ROE was 3948.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2585.4 percentage points from the prior year.

Capital Allocation

R&D Spending

$366.0M

YoY+3.1%

5Y CAGR+4.8%

10Y CAGR+2.9%

Colgate Palmolive Co invested $366.0M in research and development in fiscal year 2025. This represents an increase of 3.1% from the prior year.

Share Buybacks

$1.2B

YoY-30.4%

5Y CAGR-3.9%

10Y CAGR-2.5%

Colgate Palmolive Co spent $1.2B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 30.4% from the prior year.

Capital Expenditures

$564.0M

YoY+0.5%

5Y CAGR+6.6%

10Y CAGR-2.0%

Colgate Palmolive Co invested $564.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 0.5% from the prior year.

CL Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$20.4B+1.4%	$20.1B+3.3%	$19.5B+8.3%	$18.0B+3.1%	$17.4B+5.8%	$16.5B
Cost of Revenue	$8.1B+2.4%	$7.9B-2.3%	$8.1B+5.3%	$7.7B+9.6%	$7.0B+9.2%	$6.5B
Gross Profit	$12.3B+0.7%	$12.2B+7.4%	$11.3B+10.5%	$10.2B-1.2%	$10.4B+3.6%	$10.0B
R&D Expenses	$366.0M+3.1%	$355.0M+3.5%	$343.0M+7.2%	$320.0M+4.2%	$307.0M+5.9%	$290.0M
SG&A Expenses	$7.9B+2.3%	$7.7B+8.1%	$7.2B+8.9%	$6.6B+2.5%	$6.4B+6.4%	$6.0B
Operating Income	$3.3B-22.5%	$4.3B+7.1%	$4.0B+37.7%	$2.9B-13.2%	$3.3B-14.2%	$3.9B
Interest Expense	$267.0M-8.6%	$292.0M-2.3%	$299.0M+73.8%	$172.0M+43.3%	$120.0M-34.8%	$184.0M
Income Tax	$798.0M-12.0%	$907.0M-3.2%	$937.0M+35.2%	$693.0M-7.5%	$749.0M-4.8%	$787.0M
Net Income	$2.1B-26.2%	$2.9B+25.6%	$2.3B+28.9%	$1.8B-17.6%	$2.2B-19.6%	$2.7B
EPS (Diluted)	$2.63-25.1%	$3.51+26.7%	$2.77+30.0%	$2.13-16.5%	$2.55-18.8%	$3.14

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$5.2B+1.9%	$5.1B+0.4%	$5.1B+4.1%	$4.9B-0.7%	$4.9B-1.7%	$5.0B-0.5%	$5.1B-0.1%	$5.1B
Cost of Revenue	$2.1B+0.1%	$2.1B+2.0%	$2.0B+6.1%	$1.9B-2.0%	$2.0B+0.2%	$2.0B-1.7%	$2.0B-1.7%	$2.0B
Gross Profit	$3.1B+3.2%	$3.0B-0.7%	$3.1B+2.7%	$3.0B+0.2%	$3.0B-3.0%	$3.1B+0.3%	$3.1B+0.9%	$3.0B
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$2.1B+5.1%	$2.0B+0.4%	$2.0B+3.4%	$1.9B+0.2%	$1.9B-4.2%	$2.0B+2.1%	$1.9B+1.2%	$1.9B
Operating Income	$91.0M-91.4%	$1.1B-1.9%	$1.1B+0.4%	$1.1B+1.1%	$1.1B-0.1%	$1.1B-2.5%	$1.1B+4.3%	$1.0B
Interest Expense	$63.0M-6.0%	$67.0M-5.6%	$71.0M+7.6%	$66.0M-1.5%	$67.0M-9.5%	$74.0M-5.1%	$78.0M+6.8%	$73.0M
Income Tax	$111.0M-50.9%	$226.0M-3.4%	$234.0M+3.1%	$227.0M+5.1%	$216.0M+2.9%	$210.0M-13.6%	$243.0M+2.1%	$238.0M
Net Income	-$36.0M-104.9%	$735.0M-1.1%	$743.0M+7.7%	$690.0M-6.5%	$738.0M+0.1%	$737.0M+0.8%	$731.0M+7.0%	$683.0M
EPS (Diluted)	N/A	$0.910.0%	$0.91+7.1%	$0.85	N/A	$0.90+1.1%	$0.89+7.2%	$0.83

CL Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$16.3B+1.8%	$16.0B-2.1%	$16.4B+4.2%	$15.7B+4.6%	$15.0B-5.5%	$15.9B
Current Assets	$5.7B+7.4%	$5.3B+0.7%	$5.3B+3.2%	$5.1B+16.3%	$4.4B+1.4%	$4.3B
Cash & Equivalents	$1.3B+17.5%	$1.1B+13.5%	$966.0M+24.6%	$775.0M-6.9%	$832.0M-6.3%	$888.0M
Inventory	$2.0B+2.3%	$2.0B+2.7%	$1.9B-6.8%	$2.1B+22.6%	$1.7B+1.1%	$1.7B
Accounts Receivable	$1.7B+10.1%	$1.5B-4.1%	$1.6B+5.5%	$1.5B+16.0%	$1.3B+2.6%	$1.3B
Goodwill	$3.1B-4.6%	$3.3B-4.0%	$3.4B+1.7%	$3.4B+2.1%	$3.3B-14.1%	$3.8B
Total Liabilities	$16.0B+3.0%	$15.5B+0.4%	$15.4B+3.4%	$14.9B+6.1%	$14.1B-5.1%	$14.8B
Current Liabilities	$6.9B+19.0%	$5.8B+21.5%	$4.7B+18.4%	$4.0B-1.2%	$4.1B-8.0%	$4.4B
Long-Term Debt	$6.9B-5.7%	$7.3B-11.3%	$8.2B-6.0%	$8.7B+21.5%	$7.2B-1.9%	$7.3B
Total Equity	$54.0M-74.5%	$212.0M-65.2%	$609.0M+51.9%	$401.0M-34.2%	$609.0M-18.0%	$743.0M
Retained Earnings	$26.6B+1.7%	$26.1B+3.4%	$25.3B+2.9%	$24.6B+0.9%	$24.4B+2.7%	$23.7B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$16.3B-6.8%	$17.5B+0.2%	$17.5B+4.9%	$16.6B+3.7%	$16.0B-4.3%	$16.8B+1.8%	$16.5B-0.5%	$16.6B
Current Assets	$5.7B-5.5%	$6.0B+0.7%	$6.0B+3.1%	$5.8B+9.3%	$5.3B-8.4%	$5.8B+2.8%	$5.6B+0.1%	$5.6B
Cash & Equivalents	$1.3B+0.7%	$1.3B+5.3%	$1.2B+9.3%	$1.1B+1.5%	$1.1B-11.2%	$1.2B+11.2%	$1.1B+2.9%	$1.1B
Inventory	$2.0B-3.7%	$2.1B-0.5%	$2.1B-0.2%	$2.1B+6.9%	$2.0B-2.6%	$2.0B+6.2%	$1.9B+0.4%	$1.9B
Accounts Receivable	$1.7B-7.3%	$1.8B+1.9%	$1.8B+2.8%	$1.7B+13.4%	$1.5B-11.2%	$1.7B-6.2%	$1.8B+0.7%	$1.8B
Goodwill	$3.1B-15.7%	$3.7B+0.2%	$3.7B+10.9%	$3.3B+1.9%	$3.3B-3.5%	$3.4B+2.1%	$3.3B-0.6%	$3.3B
Total Liabilities	$16.0B-1.9%	$16.3B-0.9%	$16.4B+3.2%	$15.9B+2.7%	$15.5B-2.7%	$15.9B-0.4%	$16.0B+0.3%	$16.0B
Current Liabilities	$6.9B+5.5%	$6.5B-4.1%	$6.8B-1.3%	$6.9B+19.1%	$5.8B+3.5%	$5.6B+4.0%	$5.3B+0.7%	$5.3B
Long-Term Debt	$6.9B-6.0%	$7.3B+2.3%	$7.1B+8.7%	$6.6B-9.9%	$7.3B-7.8%	$7.9B-2.9%	$8.1B-0.1%	$8.2B
Total Equity	$54.0M-93.7%	$856.0M+21.9%	$702.0M+93.4%	$363.0M+71.2%	$212.0M-51.3%	$435.0M+253.7%	$123.0M-46.5%	$230.0M
Retained Earnings	$26.6B-1.7%	$27.1B+1.2%	$26.7B+1.2%	$26.4B+1.0%	$26.1B+1.3%	$25.8B+1.3%	$25.5B+1.3%	$25.2B

CL Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$4.2B+2.2%	$4.1B+9.7%	$3.7B+46.5%	$2.6B-23.1%	$3.3B-10.6%	$3.7B
Capital Expenditures	$564.0M+0.5%	$561.0M-20.4%	$705.0M+1.3%	$696.0M+22.8%	$567.0M+38.6%	$409.0M
Free Cash Flow	$3.6B+2.5%	$3.5B+16.6%	$3.0B+63.4%	$1.9B-32.6%	$2.8B-16.7%	$3.3B
Investing Cash Flow	-$817.0M-53.0%	-$534.0M+28.0%	-$742.0M+53.7%	-$1.6B-170.4%	-$592.0M+24.0%	-$779.0M
Financing Cash Flow	-$3.3B+3.9%	-$3.4B-21.3%	-$2.8B-193.4%	-$952.0M+65.7%	-$2.8B+5.0%	-$2.9B
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$1.2B-30.4%	$1.7B+54.2%	$1.1B-13.8%	$1.3B-0.9%	$1.3B-10.6%	$1.5B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$1.5B+15.2%	$1.3B+42.6%	$884.0M+47.3%	$600.0M-52.7%	$1.3B+8.7%	$1.2B+17.9%	$990.0M+45.4%	$681.0M
Capital Expenditures	$177.0M+14.2%	$155.0M+43.5%	$108.0M-12.9%	$124.0M-32.6%	$184.0M+37.3%	$134.0M+14.5%	$117.0M-7.1%	$126.0M
Free Cash Flow	$1.3B+15.4%	$1.1B+42.5%	$776.0M+63.0%	$476.0M-56.1%	$1.1B+5.0%	$1.0B+18.3%	$873.0M+57.3%	$555.0M
Investing Cash Flow	-$103.0M+33.1%	-$154.0M+61.6%	-$401.0M-152.2%	-$159.0M-98.8%	-$80.0M+46.7%	-$150.0M-35.1%	-$111.0M+42.5%	-$193.0M
Financing Cash Flow	-$1.4B-32.4%	-$1.0B-151.3%	-$409.0M+10.7%	-$458.0M+64.2%	-$1.3B-41.5%	-$904.0M-7.0%	-$845.0M-134.1%	-$361.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$406.0M+41.0%	$288.0M+24.1%	$232.0M-18.3%	$284.0M-37.6%	$455.0M+54.2%	$295.0M-38.5%	$480.0M-5.7%	$509.0M

CL Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	60.1%-0.4pp	60.5%+2.3pp	58.2%+1.2pp	57.0%-2.5pp	59.6%-1.3pp	60.8%
Operating Margin	16.2%-5.0pp	21.2%+0.7pp	20.5%+4.4pp	16.1%-3.0pp	19.1%-4.5pp	23.6%
Net Margin	10.5%-3.9pp	14.4%+2.5pp	11.8%+1.9pp	9.9%-2.5pp	12.4%-3.9pp	16.4%
Return on Equity	3948.1%+2585.4pp	1362.7%+985.1pp	377.7%-67.5pp	445.1%+89.5pp	355.7%-7.1pp	362.7%
Return on Assets	13.1%-4.9pp	18.0%+4.0pp	14.0%+2.7pp	11.3%-3.0pp	14.4%-2.5pp	16.9%
Current Ratio	0.83-0.1	0.92-0.2	1.11-0.2	1.28+0.2	1.09+0.1	0.98
Debt-to-Equity	127.24+92.9	34.38+20.9	13.50-8.3	21.80+10.0	11.81+1.9	9.87
FCF Margin	17.8%+0.2pp	17.6%+2.0pp	15.6%+5.3pp	10.3%-5.5pp	15.8%-4.3pp	20.1%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	60.2%+0.7pp	59.4%-0.6pp	60.1%-0.8pp	60.8%+0.5pp	60.3%-0.8pp	61.1%+0.5pp	60.6%+0.6pp	60.0%
Operating Margin	1.7%-18.9pp	20.6%-0.5pp	21.1%-0.8pp	21.9%+0.4pp	21.5%+0.4pp	21.2%-0.4pp	21.6%+0.9pp	20.7%
Net Margin	-0.7%-15.0pp	14.3%-0.2pp	14.5%+0.5pp	14.1%-0.9pp	14.9%+0.3pp	14.6%+0.2pp	14.4%+1.0pp	13.5%
Return on Equity	-66.7%-152.5pp	85.9%-20.0pp	105.8%-84.2pp	190.1%-158.0pp	348.1%+178.7pp	169.4%-424.9pp	594.3%+297.4pp	297.0%
Return on Assets	-0.2%-4.4pp	4.2%-0.1pp	4.3%+0.1pp	4.1%-0.5pp	4.6%+0.2pp	4.4%-0.1pp	4.4%+0.3pp	4.1%
Current Ratio	0.83-0.1	0.93+0.0	0.89+0.0	0.85-0.1	0.92-0.1	1.04-0.0	1.060.0	1.06
Debt-to-Equity	127.24+118.7	8.54-1.6	10.18-7.9	18.10-16.3	34.38+16.2	18.18-48.0	66.23+30.8	35.44
FCF Margin	24.4%+2.8pp	21.6%+6.4pp	15.2%+5.5pp	9.7%-12.3pp	21.9%+1.4pp	20.5%+3.3pp	17.3%+6.3pp	11.0%

Note: The current ratio is below 1.0 (0.83), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Kimberly-Clark Corp KMB

$31.9B

Kenvue Inc. KVUE

$32.9B

Estee Lauder Companies EL

$25.0B

Unilever UL

$121.1B

Clorox Co Del CLX

$12.2B

Frequently Asked Questions

What is Colgate Palmolive Co's annual revenue?

Colgate Palmolive Co (CL) reported $20.4B in total revenue for fiscal year 2025. This represents a 1.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Colgate Palmolive Co's revenue growing?

Colgate Palmolive Co (CL) revenue grew by 1.4% year-over-year, from $20.1B to $20.4B in fiscal year 2025.

Is Colgate Palmolive Co profitable?

Yes, Colgate Palmolive Co (CL) reported a net income of $2.1B in fiscal year 2025, with a net profit margin of 10.5%.

What is Colgate Palmolive Co's EBITDA?

Colgate Palmolive Co (CL) had EBITDA of $3.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Colgate Palmolive Co have?

As of fiscal year 2025, Colgate Palmolive Co (CL) had $1.3B in cash and equivalents against $6.9B in long-term debt.

What is Colgate Palmolive Co's gross margin?

Colgate Palmolive Co (CL) had a gross margin of 60.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Colgate Palmolive Co's operating margin?

Colgate Palmolive Co (CL) had an operating margin of 16.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Colgate Palmolive Co's net profit margin?

Colgate Palmolive Co (CL) had a net profit margin of 10.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Colgate Palmolive Co pay dividends?

Yes, Colgate Palmolive Co (CL) paid $2.08 per share in dividends during fiscal year 2025.

What is Colgate Palmolive Co's return on equity (ROE)?

Colgate Palmolive Co (CL) has a return on equity of 3948.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Colgate Palmolive Co's free cash flow?

Colgate Palmolive Co (CL) generated $3.6B in free cash flow during fiscal year 2025. This represents a 2.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Colgate Palmolive Co's operating cash flow?

Colgate Palmolive Co (CL) generated $4.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Colgate Palmolive Co's total assets?

Colgate Palmolive Co (CL) had $16.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Colgate Palmolive Co's capital expenditures?

Colgate Palmolive Co (CL) invested $564.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Colgate Palmolive Co spend on research and development?

Colgate Palmolive Co (CL) invested $366.0M in research and development during fiscal year 2025.

Does Colgate Palmolive Co buy back shares?

Yes, Colgate Palmolive Co (CL) spent $1.2B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Colgate Palmolive Co have outstanding?

Colgate Palmolive Co (CL) had 802M shares outstanding as of fiscal year 2025.

What is Colgate Palmolive Co's current ratio?

Colgate Palmolive Co (CL) had a current ratio of 0.83 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Colgate Palmolive Co's debt-to-equity ratio?

Colgate Palmolive Co (CL) had a debt-to-equity ratio of 127.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Colgate Palmolive Co's return on assets (ROA)?

Colgate Palmolive Co (CL) had a return on assets of 13.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Colgate Palmolive Co's Altman Z-Score?

Colgate Palmolive Co (CL) has an Altman Z-Score of 6.68, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Colgate Palmolive Co's Piotroski F-Score?

Colgate Palmolive Co (CL) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Colgate Palmolive Co's earnings high quality?

Colgate Palmolive Co (CL) has an earnings quality ratio of 1.97x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Colgate Palmolive Co cover its interest payments?

Colgate Palmolive Co (CL) has an interest coverage ratio of 12.4x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Colgate Palmolive Co?

Colgate Palmolive Co (CL) scores 46 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.